Sonora Investment Management Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$16.9M Buy
72,887
+399
+0.6% +$81.3K 1.2% 26
2025
Q2
$13.5M Buy
72,488
+63,248
+685% +$11.8M 1% 34
2025
Q1
$1.94M Buy
9,240
+214
+2% +$41.6K 0.15% 104
2024
Q4
$1.6M Buy
9,026
+696
+8% +$128K 0.12% 114
2024
Q3
$1.64M Sell
8,330
-9
-0.1% -$1.68K 0.12% 116
2024
Q2
$1.52M Hold
8,339
0.12% 124
2024
Q1
$1.52M Buy
8,339
+143
+2% +$24.6K 0.12% 124
2023
Q4
$1.27M Sell
8,196
-3,065
-27% -$447K 0.1% 124
2023
Q3
$1.68M Sell
11,261
-852
-7% -$125K 0.14% 114
2023
Q2
$1.63M Sell
12,113
-5
-0% -$733 0.14% 117
2023
Q1
$1.93M Buy
12,118
+555
+5% +$84.8K 0.17% 107
2022
Q4
$1.87M Buy
11,563
+2,677
+30% +$410K 0.17% 110
2022
Q3
$1.36M Hold
8,886
0.17% 92
2022
Q2
$1.36M Buy
8,886
+2,009
+29% +$307K 0.13% 122
2022
Q1
$1.11M Sell
6,877
-134
-2% -$19.5K 0.13% 107
2021
Q4
$949K Buy
+7,011
New +$828K 0.11% 110

Other funds holding ABBV

Sonora Investment Management Group's ABBV Position: Q3 2025 in Review

Sonora Investment Management Group increased its AbbVie (ABBV) stake by 0.55% in Q3 2025, buying an estimated $81.3K and bringing the position to 72,887 shares worth $16.9M. The position accounts for 1.2% of the portfolio, ranked #26.

Sonora Investment Management Group first reported a position in ABBV in Q4 2021 and has held it in 16 quarters since. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Sonora Investment Management Group held 72,887 shares of AbbVie worth $16.9M as of Q3 2025.
  • Sonora Investment Management Group bought 399 AbbVie shares in Q3 2025, an estimated $81.3K.
  • AbbVie made up 1.2% of Sonora Investment Management Group's portfolio in Q3 2025, its #26 holding.
  • Sonora Investment Management Group first reported a position in AbbVie in Q4 2021 and has held it in 16 quarters since.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Sonora Investment Management Group's 13F filing for Q3 2025, filed 7 Oct 2025.